Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?

Bronchodilators provide improvements in lung function and reductions in symptoms and exacerbations, and are the mainstay of pharmacological management of chronic obstructive pulmonary disease (COPD). The Global Initiative for Chronic Obstructive Lung Disease strategy recommends the use of a combinat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Tuberc Respir Dis (Seoul)
Hauptverfasser: Miravitlles, Marc, Baek, Seungjae, Vithlani, Vatsal, Lad, Rahul
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Academy of Tuberculosis and Respiratory Diseases 2018
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6030660/
https://ncbi.nlm.nih.gov/pubmed/29926556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2018.0040
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge